US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
PT950067E
(pt)
*
|
1996-11-27 |
2007-12-06 |
Genentech Inc |
Purificação por afinidade de um polipéptido numa matriz de proteína a.
|
AU760048B2
(en)
*
|
1998-05-06 |
2003-05-08 |
Genentech Inc. |
Protein purification by ion exchange chromatography
|
US20030086924A1
(en)
*
|
1999-06-25 |
2003-05-08 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
AU2001259271A1
(en)
*
|
2000-04-28 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
US20020119148A1
(en)
|
2000-09-01 |
2002-08-29 |
Gerritsen Mary E. |
ErbB4 antagonists
|
CA2448788C
(en)
|
2001-06-05 |
2010-08-24 |
Genetics Institute, Llc. |
Methods for purifying highly anionic proteins
|
US7452539B2
(en)
*
|
2001-12-19 |
2008-11-18 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
EP1463942B2
(de)
*
|
2001-12-21 |
2012-06-20 |
Immunex Corporation |
Proteinreinigungsverfahren
|
WO2003066662A2
(en)
*
|
2002-02-05 |
2003-08-14 |
Genentech, Inc. |
Protein purification
|
EP3388452A3
(de)
|
2002-09-11 |
2019-02-20 |
Genentech, Inc. |
Proteinreinigung
|
EP2261230B1
(de)
|
2002-09-11 |
2017-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur Proteinreinigung
|
EP1626993B1
(de)
*
|
2003-05-09 |
2015-03-11 |
Duke University |
Cd20-spezifische antikörper und verfahren zur anwendung derselben
|
SI3095793T1
(sl)
*
|
2003-07-28 |
2020-07-31 |
Genentech, Inc. |
Zmanjšanje izluževanja proteina A med afinitetno kromatografijo proteina A
|
US20050065136A1
(en)
*
|
2003-08-13 |
2005-03-24 |
Roby Russell R. |
Methods and compositions for the treatment of infertility using dilute hormone solutions
|
JP2007504144A
(ja)
|
2003-08-26 |
2007-03-01 |
ザ リージェンツ オブ ザ ユニバーシティー オブ コロラド ア ボディー コーポレイト |
セリンプロテアーゼ活性阻害因子、ならびに細菌感染の治療法および組成物におけるその使用方法
|
US20050165222A1
(en)
*
|
2003-10-15 |
2005-07-28 |
Applera Corporation |
Method of reducing leachate from protein a affinity media
|
US20050130246A1
(en)
*
|
2003-10-27 |
2005-06-16 |
Hossein Salimi-Moosavi |
Detecting human anti-therapeutic antibodies
|
CA2544865C
(en)
|
2003-11-05 |
2019-07-09 |
Glycart Biotechnology Ag |
Cd20 antibodies with increased fc receptor binding affinity and effector function
|
US20050239757A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Roby Russell R |
Hormone treatment of macular degeneration
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
KR20170134771A
(ko)
|
2005-01-21 |
2017-12-06 |
제넨테크, 인크. |
Her 항체의 고정 용량 투여법
|
MX2007009566A
(es)
*
|
2005-02-09 |
2009-02-16 |
Genentech Inc |
Inhibicion de la difusion de la her2 con antagonistas de la metaloproteasa de matriz.
|
KR101253576B1
(ko)
|
2005-02-23 |
2013-04-11 |
제넨테크, 인크. |
Her 이량체화 억제제를 이용한 암 환자에서의 질환진행까지의 시간 또는 생존의 연장
|
US20090247421A1
(en)
*
|
2005-03-23 |
2009-10-01 |
Egisto Boschetti |
Diverse chemical libraries bound to small particles with paramagnetic properties
|
CA2602951A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Bio-Rad Laboratories, Inc. |
Diverse chemical libraries bound to small particles with paramagnetic properties
|
JP2006316040A
(ja)
|
2005-05-13 |
2006-11-24 |
Genentech Inc |
Herceptin(登録商標)補助療法
|
PE20070207A1
(es)
*
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
CN102827287B
(zh)
*
|
2005-10-31 |
2015-08-12 |
昂考梅德药品有限公司 |
用于诊断和治疗癌症的组合物和方法
|
AU2006330922B2
(en)
|
2005-12-20 |
2012-07-26 |
Bristol-Myers Squibb Company |
Compositions and methods for producing a composition
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
CA2636109A1
(en)
*
|
2006-01-06 |
2007-07-19 |
Amgen Inc. |
Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents
|
US8263750B2
(en)
*
|
2006-03-16 |
2012-09-11 |
Amgen Inc. |
Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
PE20080913A1
(es)
*
|
2006-09-08 |
2008-08-21 |
Wyeth Corp |
Lavado de arginina en la purificacion de proteinas usando cromatografia de afinidad
|
NZ575328A
(en)
|
2006-09-13 |
2012-06-29 |
Abbott Lab |
Cell culture improvements
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
EP2089429B1
(de)
*
|
2006-10-19 |
2014-11-26 |
Janssen Biotech, Inc. |
Verfahren zur herstellung nicht aggregierter antikörper-fc-domänen
|
WO2008079302A2
(en)
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification of proteins
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
US8362217B2
(en)
*
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
US7947813B2
(en)
|
2007-01-22 |
2011-05-24 |
Genentech, Inc. |
Polyelectrolyte precipitation and purification of proteins
|
AU2008208837A1
(en)
*
|
2007-01-26 |
2008-07-31 |
Merck Serono S.A. |
Purification of Fc-TACT fusion proteins using the oilbody technology
|
EP2899541A1
(de)
|
2007-03-02 |
2015-07-29 |
Genentech, Inc. |
Voraussage der Reaktion auf einen HRE-Dimerisationshemmer auf Basis niedriger HER3-Expression
|
PL2171090T3
(pl)
|
2007-06-08 |
2013-09-30 |
Genentech Inc |
Markery ekspresji genów odporności guza na leczenie hamujące HER2
|
US9551033B2
(en)
*
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
PL3327026T3
(pl)
|
2007-07-09 |
2020-02-28 |
Genentech, Inc. |
Zapobieganie redukcji wiązań disiarczkowych podczas rekombinacyjnego wytwarzania polipeptydów
|
DK2215117T4
(en)
|
2007-10-30 |
2018-04-09 |
Genentech Inc |
ANTISTO PURIFICATION BY CATION CHANGE CHROMATOGRAPHY
|
TWI472339B
(zh)
*
|
2008-01-30 |
2015-02-11 |
Genentech Inc |
包含結合至her2結構域ii之抗體及其酸性變異體的組合物
|
US8999702B2
(en)
*
|
2008-06-11 |
2015-04-07 |
Emd Millipore Corporation |
Stirred tank bioreactor
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
TW201014605A
(en)
|
2008-09-16 |
2010-04-16 |
Genentech Inc |
Methods for treating progressive multiple sclerosis
|
JP5792621B2
(ja)
*
|
2008-09-26 |
2015-10-14 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
frizzled結合剤およびその使用
|
US8551789B2
(en)
|
2010-04-01 |
2013-10-08 |
OncoMed Pharmaceuticals |
Frizzled-binding agents and their use in screening for WNT inhibitors
|
AU2009307737B2
(en)
|
2008-10-20 |
2015-07-23 |
Abbvie Inc. |
Viral inactivation during purification of antibodies
|
JP5808249B2
(ja)
|
2008-10-20 |
2015-11-10 |
アッヴィ・インコーポレイテッド |
プロテインaアフィニティークロマトグラフィーを用いる抗体の単離および精製
|
JP2012511929A
(ja)
*
|
2008-12-16 |
2012-05-31 |
イー・エム・デイー・ミリポア・コーポレイシヨン |
攪拌タンク反応器及び方法
|
US8846878B1
(en)
*
|
2009-01-23 |
2014-09-30 |
Cubrc Corporation |
Method and device for isolating a protein sample
|
AR075896A1
(es)
|
2009-03-20 |
2011-05-04 |
Genentech Inc |
Anticuerpos anti-her (factor de crecimiento epidermico)
|
SG10201507044PA
(en)
|
2009-05-29 |
2015-10-29 |
Hoffmann La Roche |
Modulators for her2 signaling in her2 expressing patients with gastric cancer
|
SG178078A1
(en)
*
|
2009-07-24 |
2012-03-29 |
Hoffmann La Roche |
Optimizing the production of antibodies
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
WO2011038894A1
(en)
|
2009-10-01 |
2011-04-07 |
F. Hoffmann-La Roche Ag |
Protein a chromatography
|
DK2483305T3
(en)
|
2009-10-01 |
2016-10-24 |
Hoffmann La Roche |
MULTI-STEP-END FILTERING Immunoglobulin
|
WO2011060242A2
(en)
|
2009-11-13 |
2011-05-19 |
Talecris Biotherapeutics, Inc. |
Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
|
DK2513134T3
(en)
|
2009-12-18 |
2017-12-18 |
Novartis Ag |
Washing solution and process for affinity chromatography
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
KR101551295B1
(ko)
|
2010-05-17 |
2015-09-08 |
이엠디 밀리포어 코포레이션 |
생체분자 정제용 자극 반응성 중합체
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
EP2643353A1
(de)
|
2010-11-24 |
2013-10-02 |
Novartis AG |
Multispezifische moleküle
|
WO2012082933A1
(en)
|
2010-12-15 |
2012-06-21 |
Baxter International, Inc. |
Eluate collection using conductivity gradient
|
EP2655413B1
(de)
|
2010-12-23 |
2019-01-16 |
F.Hoffmann-La Roche Ag |
Polypeptid-polynukleotid-komplex und verwendung bei der gezielten effektorrest-bereitstellung
|
EP2702077A2
(de)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen
|
KR102103476B1
(ko)
|
2011-06-24 |
2020-04-23 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
KR20140057326A
(ko)
|
2011-08-17 |
2014-05-12 |
제넨테크, 인크. |
뉴레귤린 항체 및 그의 용도
|
US20130095172A1
(en)
|
2011-10-14 |
2013-04-18 |
Genentech, Inc. |
Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
|
US9327023B2
(en)
|
2011-10-25 |
2016-05-03 |
The Regents Of The University Of Michigan |
HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells
|
PL2773438T5
(pl)
*
|
2011-11-02 |
2022-01-17 |
F.Hoffmann-La Roche Ag |
Chromatografia przeciążenia i elucji
|
CN106987620A
(zh)
|
2011-11-30 |
2017-07-28 |
霍夫曼-拉罗奇有限公司 |
癌症中的erbb3突变
|
EP2788500A1
(de)
|
2011-12-09 |
2014-10-15 |
F.Hoffmann-La Roche Ag |
Identifizierung von non-respondern auf her2-inhibitoren
|
KR20140137347A
(ko)
|
2012-01-10 |
2014-12-02 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
WO2013148315A1
(en)
|
2012-03-27 |
2013-10-03 |
Genentech, Inc. |
Diagnosis and treatments relating to her3 inhibitors
|
EP2647709B1
(de)
*
|
2012-04-05 |
2016-02-24 |
F. Hoffmann-La Roche AG |
Aminverbindungen für die selektive Herstellung von biologischen Proben
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
WO2013177118A2
(en)
*
|
2012-05-21 |
2013-11-28 |
Abbvie Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
CA2883272A1
(en)
|
2012-09-02 |
2014-03-06 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
SG11201404684RA
(en)
|
2012-09-17 |
2014-10-30 |
Grace W R & Co |
Functionalized particulate support material and methods of making and using the same
|
PL2812091T3
(pl)
|
2012-09-17 |
2021-07-19 |
W.R. Grace & Co. - Conn. |
Podłoża chromatograficzne i urządzenia
|
JP2015536933A
(ja)
|
2012-10-23 |
2015-12-24 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Wnt経路結合剤を用いて神経内分泌腫瘍を処置する方法
|
KR102291355B1
(ko)
|
2012-11-30 |
2021-08-19 |
에프. 호프만-라 로슈 아게 |
Pd-l1 억제제 공동치료를 필요로 하는 환자의 식별방법
|
WO2014121196A1
(en)
|
2013-02-04 |
2014-08-07 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|
MX2015012114A
(es)
|
2013-03-08 |
2016-01-12 |
Genzyme Corp |
Fabricacion continua integrada de principios activos proteinicos terapeuticos.
|
CA2905010A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
US9499614B2
(en)
|
2013-03-14 |
2016-11-22 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
|
US8921526B2
(en)
|
2013-03-14 |
2014-12-30 |
Abbvie, Inc. |
Mutated anti-TNFα antibodies and methods of their use
|
CA3071678A1
(en)
|
2013-04-16 |
2014-10-23 |
Genentech,Inc. |
Pertuzumab variants and evaluation thereof
|
WO2014192877A1
(ja)
*
|
2013-05-29 |
2014-12-04 |
Jsr株式会社 |
洗浄用組成物、タンパク質精製方法、及びタンパク質
|
JP6141524B2
(ja)
*
|
2013-07-12 |
2017-06-07 |
メルク パテント ゲーエムベーハー |
活性炭を用いた標的タンパク質含有サンプルからのフラグメントの除去
|
PL3044323T3
(pl)
|
2013-09-13 |
2022-06-27 |
F.Hoffmann-La Roche Ag |
Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
|
NZ756750A
(en)
*
|
2013-09-13 |
2022-05-27 |
Genentech Inc |
Methods and compositions comprising purified recombinant polypeptides
|
WO2015051293A2
(en)
|
2013-10-04 |
2015-04-09 |
Abbvie, Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
CN105407905B
(zh)
|
2014-01-03 |
2020-03-03 |
生物辐射实验室股份有限公司 |
蛋白a洗脱产物中杂质的去除
|
US11229896B2
(en)
|
2014-01-16 |
2022-01-25 |
W.R. Grace & Co.—Conn. |
Affinity chromatography media and chromatography devices
|
TWI709569B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析樹脂及其用於製造方法的用途
|
TWI709570B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析法及製法
|
SG10201809411PA
(en)
|
2014-04-25 |
2018-11-29 |
Genentech Inc |
Methods of treating early breast cancer with trastuzumab-mcc-dm1 and pertuzumab
|
PL3137209T3
(pl)
|
2014-05-02 |
2023-01-02 |
W.R. Grace & Co. - Conn. |
Funkcjonalizowany materiał nośnikowy i sposoby wytwarzania oraz stosowania funkcjonalizowanego materiału nośnikowego
|
US11566082B2
(en)
|
2014-11-17 |
2023-01-31 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
CN107614015A
(zh)
|
2015-05-30 |
2018-01-19 |
豪夫迈·罗氏有限公司 |
治疗her2阳性局部晚期或先前未治疗的转移性乳腺癌的方法
|
JP2018517559A
(ja)
|
2015-06-05 |
2018-07-05 |
ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn |
吸着性バイオプロセス清澄化剤並びにその製造及び使用方法
|
WO2017087280A1
(en)
|
2015-11-16 |
2017-05-26 |
Genentech, Inc. |
Methods of treating her2-positive cancer
|
WO2017194554A1
(en)
|
2016-05-10 |
2017-11-16 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Combinations therapies for the treatment of cancer
|
CN109311949B
(zh)
|
2016-05-11 |
2022-09-16 |
思拓凡生物工艺研发有限公司 |
储存分离基质的方法
|
EP3455241B1
(de)
|
2016-05-11 |
2022-02-23 |
Cytiva BioProcess R&D AB |
Verfahren zur reinigung und/oder sanierung einer trennmatrix
|
US10654887B2
(en)
|
2016-05-11 |
2020-05-19 |
Ge Healthcare Bio-Process R&D Ab |
Separation matrix
|
US10889615B2
(en)
|
2016-05-11 |
2021-01-12 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
US10730908B2
(en)
|
2016-05-11 |
2020-08-04 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
WO2017194597A1
(en)
|
2016-05-11 |
2017-11-16 |
Ge Healthcare Bioprocess R&D Ab |
Separation matrix
|
US10703774B2
(en)
|
2016-09-30 |
2020-07-07 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
WO2018045587A1
(zh)
*
|
2016-09-12 |
2018-03-15 |
广东东阳光药业有限公司 |
一种抗vegf类单克隆抗体的纯化方法
|
EP3534948A1
(de)
|
2016-11-04 |
2019-09-11 |
Genentech, Inc. |
Behandlung von her2-positivem brustkrebs
|
CN110099926A
(zh)
|
2016-12-28 |
2019-08-06 |
豪夫迈·罗氏有限公司 |
晚期her2表达性癌症的治疗
|
CR20190376A
(es)
|
2017-01-17 |
2019-11-20 |
Genentech Inc |
Formulaciones de anticuerpos de her2 subcutáneas
|
EP3589661B1
(de)
|
2017-03-02 |
2023-11-01 |
Genentech, Inc. |
Adjuvansbehandlung von her2-positivem brustkrebs
|
TW201902509A
(zh)
|
2017-04-24 |
2019-01-16 |
美商建南德克公司 |
Erbb2/her2突變
|
ES2887046T3
(es)
|
2017-08-17 |
2021-12-21 |
Just Evotec Biologics Inc |
Método de purificación de proteína glicosilada a partir de galectinas de las células hospedadoras y otros contaminantes
|
JP2021536353A
(ja)
|
2018-08-31 |
2021-12-27 |
ジェンザイム・コーポレーション |
無菌クロマトグラフィー樹脂および製造方法におけるその使用
|
SG11202110947RA
(en)
|
2019-04-02 |
2021-10-28 |
Bondwell Tech Inc |
Functionalized ubx protein materials for enhanced purification of antibodies
|